Two of the challenges for malignant mesothelioma cancer are early diagnosis and predicting whether patients will respond well to treatment. Could your breath be a solution to...
Read PostThe family of a former engineer who passed away from mesothelioma received a $40.75 million verdict from a jury in Cook County, Illinois. The verdict was awarded in August and...
Read PostAnother Criteria for Mesothelioma Surgery: Patient Response to Neoadjuvant Therapy
By: Devin Golden
September 12, 2023
Mesothelioma surgery is one of the best ways to eliminate and defeat this aggressive cancer, but not every patient is a candidate for a radical surgery. There are a few criteria...
Read PostTalc, also known as talcum powder, has been a controversial ingredient in various products and materials for decades. It is a naturally occurring mineral often found near...
Read PostAsbestos Disease Clinic in Libby Faces Controversy, Files for Bankruptcy
By: Devin Golden
August 31, 2023
The Center for Asbestos Related Disease (CARD) clinic in Libby, Montana – a town infamously known for asbestos exposure and diseases – is facing controversy due to alleged...
Read PostLung Cancer Victims Receive $38 Million Verdict for Asbestos Exposure
By: Devin Golden
August 28, 2023
Romeo and Rosa M. received $38 million in a verdict against Burnham Boilers for Romeo’s asbestos lung cancer. Romeo worked with hundreds of Burnham boilers in the 1970s and...
Read PostUPDATE (03/18/2024): The EPA banned chrysotile asbestos in the United States. The ban prevents the import, manufacturing, production, sale, distribution and use of chrysotile...
Read PostAny time you find asbestos in your home or believe asbestos might be hiding in floor tiles or drywall joint compound mixture, you should call a professional to assess the area....
Read PostMesothelioma Guide is a useful resource for patients with mesothelioma and their loved ones. We create and provide easy-to-understand information on the mesothelioma diagnostic...
Read PostT-cell Therapy Leads to Positive Response for Mesothelioma Patients
By: Devin Golden
August 10, 2023
A novel type of cancer cell and gene therapy performed well in a phase 1 clinical trial that consisted of patients with mesothelioma. The therapy, called gavocabtagene autoleucel,...
Read Post